CNE100000W45
CNE100000W45
JOINTOWN PHARMACEUTICAL GROUP C
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 161.389.993.007 | 151.809.798.857 | 6.3% |
| Cost of Revenue | 148.840.428.201 | 139.967.716.268 | 6.3% |
| Gross Profit | 12.549.564.806 | 11.842.082.589 | 6.0% |
| 8.506.116.503 | 7.628.517.752 | 11.5% | |
| Operating Income | 4.043.448.303 | 4.213.564.837 | 4.0% |
| Pretax Income | 3.289.816.562 | 3.637.468.778 | 9.6% |
| Net Income Common Stockholders | 2.254.863.863 | 2.507.391.944 | 10.1% |
| -- | -- | -- | |
| -- | -- | -- |